Price And Utilization Of New Drugs Under A Single Public Payer System- Evidence From Taiwan
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.569
https://www.valueinhealthjournal.com/article/S1098-3015(16)31935-0/fulltext
Section Title :
Health Care Use & Policy Studies
Section Order :
531
First Page :
A444
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31935-0&doi=10.1016/j.jval.2016.09.569